Upton: Bipartisan Allergy Bill Helps Save Children’s Lives
Nearly 6 million children in the United States have food allergies – that’s roughly two students in every classroom. Anaphylaxis, a serious form of allergic reaction, can be fatal in a matter of minutes. In the event of an allergic reaction, epinephrine can be used to stop deadly swelling of the throat and tongue that occurs in an anaphylactic reaction.
This evening, the U.S. House of Representatives approved the bipartisan the School Access to Emergency Epinephrine Act, H.R. 2094, which supports our nation’s schools as they work to ensure they have the capability to treat severe allergic reactions. Congressman Fred Upton, R-St. Joseph, praised the passage of the bill, which was recently advanced by his Energy and Commerce Committee.
“A child having a serious allergic reaction at school is a parent and teacher’s worst nightmare,” said Upton. “When the difference between life and death comes down to a matter of minutes, ensuring that an emergency supply of epinephrine is available onsite is a matter of commonsense. This bipartisan legislation goes a long way to standardize this lifesaving practice, keeping our classrooms safe and saving untold lives in the process.”
Coauthored by Congressman Phil Roe (R-TN) and Democratic Whip Steny Hoyer (D-MD), H.R. 2094 would provide an incentive for states to allow schools to maintain an emergency supply of epinephrine auto-injectors and permit trained school personnel to administer a non-student specific epinephrine shot in case of an emergency. The legislation also requires states to review their own civil liability protection laws to ensure there is adequate protection for school personnel authorized to aid students.